TelyRx Holdings Inc.
TELY.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | -12,205.26% | -247.03% | -- | ||
| Total Depreciation and Amortization | -28.68% | 515.63% | -- | ||
| Total Amortization of Deferred Charges | -- | -26.20% | -- | ||
| Total Other Non-Cash Items | 981.12% | -71.75% | -- | ||
| Change in Net Operating Assets | 1,545.37% | 607.46% | -- | ||
| Cash from Operations | -1,090.23% | -14.17% | -- | ||
| Capital Expenditure | 76.54% | -79.41% | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 367.78% | 74.91% | -- | ||
| Cash from Investing | 250.12% | 31.25% | -- | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -57,731.25% | 39.01% | -- | ||
| Issuance of Common Stock | -- | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | 154,625.00% | -40.54% | -- | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 8,553.87% | -50.48% | -- | ||